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Abstract In this study we analyzed the interaction of prion
protein PrPC with components of glycosphingolipid-enriched mi-
crodomains in lymphoblastoid T cells. PrPC was distributed in
small clusters on the plasma membrane, as revealed by immu-
noelectron microscopy. PrPC is present in microdomains, since
it coimmunoprecipitates with GM3 and the raft marker GM1.
A strict association between PrPC and Fyn was revealed by
scanning confocal microscopy and coimmunoprecipitation ex-
periments. The phosphorylation protein ZAP-70 was immuno-
precipitated by anti-PrP after T cell activation. These results
demonstrate that PrPC interacts with ZAP-70, suggesting that
PrPC is a component of the multimolecular signaling complex
within microdomains involved in T cell activation.
) 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Prions are unprecedented infectious pathogens that cause a
group of invariably fatal neurodegenerative diseases mediated
by an entirely novel mechanism. Prion diseases may present as
genetic, infectious, or sporadic disorders, all of which involve
modi¢cation of the prion protein PrPC, as a constituent of
mammalian cells [1].
PrPC is a highly conserved glycoprotein bound to the cell
surface by glycosylphosphatidylinositol (GPI)-anchored link-
age in neurons and other cells [2], including lymphocytes [3].
Although there is much information available on the role of
PrPSc in the disease process, relatively little is known about
the physiological functions of PrPC. Like other GPI-anchored
proteins, most of PrPC as well as PrPSc were found in choles-
terol-enriched, detergent-resistant microdomains (‘rafts’) of
the neural plasma membrane [4,5], which are also enriched
in several cytoplasmic proteins, including tyrosine kinases
[6]. The association with these specialized portions of the
cell plasma membrane is required for conversion of PrPC to
the transmissible spongiform encephalopathy-associated pro-
tease-resistant isoform [5,7].
PrPC has been also detected in human lymphocytes [8],
where the level of PrPC was up-regulated as a consequence
of T cell activation [3]. The host immune system has been
shown to play a role in the pathogenesis of prion disease in
animal models [9,10], but the mechanism by which it partic-
ipates in the propagation of PrPSc is not known.
In human lymphocytes glycosphingolipid-enriched micro-
domains (GEM) were observed [11]. In these microdomains
GM3 represents the main ganglioside constituent [12] and is
involved in modulating signal transduction by assembly with
signal transducer molecules, including Fyn, Lck [13] and, after
activation, the phosphorylation protein ZAP-70 [12]. In a pre-
liminary study [14] we demonstrated a speci¢c PrPC^GM3
association within microdomains of human T cells.
The aim of this study was to evaluate a possible role of
PrPC in tyrosine signaling pathway triggered by GEM in
T cells. In this concern, we demonstrated the interaction of
PrPC with the transducer protein ZAP-70, which plays a key
role in the transduction signaling pathway ending to T cell
activation.
2. Materials and methods
2.1. Immunoelectron microscopy
Human lymphoblastoid CEM cells were incubated with anti-PrP
monoclonal antibody (MoAb) (6H4, Prion Diagnostica, Milan, Italy)
for 1 h at 4‡C. Cells were ¢xed with 2% glutaraldehyde (1 h at 4‡C),
washed and labeled with protein A-colloidal gold (Pharmacia Fine
Chemicals, Uppsala, Sweden) for 3 h at 4‡C. Cells were post-¢xed
in osmium tetroxide 1% in Veronal acetate bu¡er, pH 7.4, for 2 h at
4‡C, stained with uranyl acetate (5 mg/ml), dehydrated in acetone and
embedded in Epon 812. Samples were then sectioned and examined
under an electron microscope (Philips CM10, Eindhoven, The Nether-
lands).
2.2. Immunoprecipitation experiments
Brie£y, CEM cells were lysed in lysis bu¡er (20 mM HEPES, pH
7.2, 1% Nonidet P-40, 10% glycerol, 50 mM NaF, including protease
inhibitors). Parallel experiments were performed using Triton X-100
as detergent and the results were virtually the same. After preclearing,
the supernatant was immunoprecipitated with the polyclonal anti-PrP
(C-20) or anti-Fyn (FYN3) (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) plus protein A-acrylic beads. The immunoprecipitates were
checked by Western blot, using the anti-PrP MoAb (6H4) or anti-Fyn
MoAb (FYN15, Santa Cruz).
The PrPC immunoprecipitate was subjected to ganglioside extrac-
tion according to the method of Svennerholm and Fredman [15]. The
eluted glycosphingolipids were dried and separated by high-perfor-
mance thin-layer chromatography (HPTLC) aluminum-backed silica
gel 60 (20U20) plates (Merck, Darmstadt, Germany). Chromatogra-
phy was performed in chloroform:methanol:0.25% aqueous KCl
(5:4:1, v:v:v). Plates were immunostained for 1 h at room temper-
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ature with horseradish peroxidase-conjugated cholera toxin, B subunit
(CTxB) (Sigma, St Louis, MO, USA), or, alternatively, with GMR6
anti-GM3 MoAb (Seikagaku, Chuo-ku, Tokyo, Japan) and then
horseradish peroxidase-conjugated anti-mouse IgM (Sigma). Immuno-
reactivity was assessed by chemiluminescence reaction using the ECL
Western blocking detection system (Amersham, Buckinghamshire,
UK).
The Fyn immunoprecipitate was analyzed by Western blot with the
anti-PrP (C-20).
2.3. Analysis of PrPC^Fyn colocalization on the cell surface by
scanning confocal microscopy
CEM cells were labeled with anti-PrP 6H4, for 1 h at 4‡C, followed
by addition (45 min at 4‡C) of £uorescein isothiocyanate (FITC)-
conjugated anti-mouse IgG (Sigma). The cells were ¢xed in acetone/
methanol (1:1, v:v) in phosphate-bu¡ered saline for 5 min at 4‡C and
then labeled with anti-Fyn (FYN3) or anti-Src (pp60src, Biomol, Ply-
mouth Meeting, PA, USA) polyclonal antibodies for 1 h at 4‡C,
followed by addition (45 min at 4‡C) of Texas red-conjugated anti-
rabbit IgG (Calbiochem, La Jolla, CA, USA). The images were ac-
quired with a Leica TCS SP2 confocal laser scanning microscope.
Images were collected at 512U512 pixels and processed with the con-
focal software 4.7.
2.4. Coimmunoprecipitation of PrPC and ZAP-70
Immunoprecipitation of PrPC was performed as reported above
from untreated or treated cells (anti-CD3, Ortho-Clinical Diagnostics,
Ratinan, NJ, USA, plus anti-CD28, Pharmingen, La Jolla, CA, USA,
10 Wg/ml) for 1 h at 37‡C. The immunoprecipitates were analyzed by
Western blot with polyclonal anti-ZAP-70 (LR, Santa Cruz).
3. Results
3.1. PrPC distribution on CEM cell plasma membrane
To investigate the cell surface distribution of PrPC, immu-
noelectron microscopy was performed. It showed an uneven
distribution of PrPC on the cell plasma membrane. The gold
immunolabeling was distributed in small clusters (Fig. 1).
3.2. PrPC^ganglioside interaction
Since gangliosides GM3 [12] and GM1 [16] have been
shown to be components of the signaling complex within mi-
crodomains involved in T cell activation, we investigated the
interaction of PrPC with these gangliosides. Acidic glycosphin-
golipids, extracted from the PrPC immunoprecipitates, were
immunostained by a high selective anti-GM3 MoAb [17]
and by CTxB, indicating that PrPC strictly interacts with
GM3 (Fig. 2B) and GM1 in CEM cell microdomains (Fig.
2E). The immunoprecipitate was revealed as PrPC, as detected
by Western blot, using the anti-PrP MoAb (not shown). In
control samples the immunoprecipitation with IgG with irrel-
evant speci¢city, under the same condition, did not result in
detectable levels of gangliosides (Fig. 2C^F).
3.3. PrPC^Fyn association on cell plasma membrane
We analyzed the possible association of PrPC with Fyn, a
protein involved in the signal transduction pathway triggered
by PrPC in neural cells [18].
The results obtained by scanning confocal microscopy con-
¢rmed that most of the cells showed an uneven signal distri-
bution of PrPC molecules over the CEM cell plasma mem-
brane (Fig. 3A,D). Similar staining was obtained with the
anti-Fyn antibody (Fig. 3B). In order to determine the possi-
ble association between PrPC and Fyn, we superimposed the
double immunostaining of PrPC and Fyn. The merged image
of anti-PrPC and anti-Fyn staining revealed yellow areas, re-
sulting from the overlap of green and red £uorescence, which
correspond to nearly complete colocalization areas (Fig. 3C).
As a control, we analyzed the possible association of PrPC
with the monoacylated kinase Src (Fig. 3E). The merged im-
age of anti-PrPC and anti-Src revealed minimal colocalization
areas, indicating a weak association between the two proteins
(Fig. 3F).
Fig. 1. Immunolabeling of PrPC on CEM plasma membrane. Small clusters are localized over the microvilli and over the non-villous portion
of the plasma membranes.
Fig. 2. Coimmunoprecipitation of PrPC and gangliosides. CEM cells
were immunoprecipitated with anti-PrP. The immunoprecipitates
were subjected to ganglioside extraction and analyzed by HPTLC.
A: Reactivity of anti-GM3 MoAb with standard GM3. B: Reactiv-
ity of anti-GM3 MoAb with PrPC immunoprecipitate. C: Reactivity
of anti-GM3 MoAb with immunoprecipitate with IgG with irrele-
vant speci¢city. D: Reactivity of CTxB with standard GM1. E: Re-
activity of CTxB with PrPC immunoprecipitate. F: Reactivity of
CTxB with immunoprecipitate with IgG with irrelevant speci¢city.
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These ¢ndings indicate that PrPC associates with Fyn on
the plasma membrane of CEM cells.
3.4. PrPC^Fyn coimmunoprecipitation
To verify whether PrPC interacts with Fyn, cell-free lysates
from CEM cells, either untreated or stimulated with anti-CD3
(10 Wg/ml) plus anti-CD28 (10 Wg/ml), were immunoprecipi-
tated with the polyclonal anti-Fyn, followed by protein A-
acrylic beads. Western blot analysis of the immunoprecipitates
showed an about 35 kDa band, recognized by anti-PrP C-20,
which was present in untreated cells (Fig. 4A), as well as after
CD28/CD3 triggering (Fig. 4C). The immunoprecipitate was
revealed as Fyn, as detected by Western blot using the anti-
Fyn MoAb (not shown). No band was detected in the immu-
noprecipitates with IgG with irrelevant speci¢city, under the
same condition (Fig. 4B).
3.5. PrPC^ZAP-70 coimmunoprecipitation after CD28/CD3
triggering
To verify the possible PrPC interaction with ZAP-70, cell-
free lysates from anti-CD3- and anti-CD28-treated and un-
treated cells were immunoprecipitated with the polyclonal
anti-PrP, followed by protein A-acrylic beads. Western blot
analysis of the immunoprecipitates revealed the presence of a
70 kDa band, recognized by anti-ZAP-70, which was present
in the immunoprecipitates from activated cells (Fig. 5C). To
con¢rm the positive band as PrPC, the anti-ZAP-70 was
Fig. 3. Scanning confocal microscopic analysis of PrPC association with Fyn and Src on cell plasma membrane. CEM cells were labeled with
anti-PrP 6H4, followed by FITC-conjugated anti-mouse IgG. Cells were incubated with anti-Fyn or anti-Src, followed by Texas red-conjugated
anti-rabbit IgG.
Fig. 4. Coimmunoprecipitation of Fyn and PrPC. CEM cells were
immunoprecipitated with anti-Fyn FYN3. The immunoprecipitates
were analyzed by Western blotting with anti-PrP C-20. A: Control
cells immunoprecipitated with anti-Fyn. B: Control cells immuno-
precipitated with IgG with irrelevant speci¢city. C: Cells stimulated
with anti-CD3 (10 Wg/ml) plus anti-CD28 (10 Wg/ml), immunopreci-
pitated with anti-Fyn. D: Total cell lysate.
Fig. 5. Coimmunoprecipitation of PrPC and ZAP-70. CEM cells
were treated with anti-CD3 (10 Wg/ml) plus anti-CD28 (10 Wg/ml)
and immunoprecipitated with anti-PrP C-20. The immunoprecipi-
tates were analyzed by Western blotting with anti-ZAP-70. A: Con-
trol cells immunoprecipitated with anti-PrP. B: Control cells immu-
noprecipitated with IgG with irrelevant speci¢city. C: Cells
stimulated with anti-CD3/CD28, immunoprecipitated with anti-PrP.
D: Cells stimulated with anti-CD3/CD28, immunoprecipitated with
IgG with irrelevant speci¢city. E: Total cell lysate.
FEBS 28055 16-2-04 Cyaan Magenta Geel Zwart
V. Mattei et al./FEBS Letters 560 (2004) 14^1816
stripped from the nitrocellulose and the membrane was then
reprobed with anti-PrP 6H4 MoAb. The results showed the
positive band as PrPC (not shown). In contrast, no bands were
detectable in the immunoprecipitates with IgG with irrelevant
speci¢city (Fig. 5B^D) or from untreated cells (Fig. 5A).
4. Discussion
In this study we demonstrated the interaction of PrPC with
the transducer protein ZAP-70 after CD28 and CD3 engage-
ment, strongly suggesting a role for PrPC as a signaling mol-
ecule in lymphocytic cells. Recent insights, obtained in a neu-
ronal di¡erentiation model, indicated that PrPC may be a
signal transduction protein, since it couples to the tyrosine
kinase Fyn and is able to increase the phosphorylation levels
of the protein [18]. This binding was shown to be caveolin-1-
dependent. Thus, following the demonstration that PrPC is
associated with ganglioside molecules within microdomains
of human lymphocytic and neuronal cells [14], we investigated
PrPC^Fyn interaction in a T lymphocyte cell model. It could
be interesting, since these cells, which might play a potential
role in the propagation of the disease, lack caveolin-1 [19].
Until now, only indirect evidence suggested a role for PrPC
in signal transduction in human T lymphocytes [3,8]. On the
basis of these ¢ndings, we primarily analyzed the distribution
of PrPC in T cells, revealing that the gold immunolabeling was
distributed in small clusters. This ¢nding is supported by re-
cent papers, which have shown that prion protein is tightly
clustered on neurons by using either monovalent antibody
reagents [20] or a strong ¢xation procedure prior to labeling
[21,22]. Moreover, we demonstrated that PrPC coimmunopre-
cipitates with monosialoganglioside GM3 and with GM1, a
well known raft marker [23]. It indicates that these specialized
portions of the cell plasma membrane implicated in the signal
transduction pathway of T cells [13,24], already identi¢ed in
our previous papers [11,12], correspond to lipid rafts even if
these cells lack caveolin-1 [19]. These ¢ndings con¢rm and
extend, using TLC immunostaining, our preliminary observa-
tion on PrPC^GM3 association [14]. They are also in agree-
ment with the observations revealing that PrPC, like many
GPI-anchored proteins, resides within Triton X-100-insoluble,
cholesterol- and sphingolipid-rich rafts in neuronal cells [25].
Moreover, this investigation showed a strict association be-
tween PrPC and Fyn in lymphocytic cells, as revealed by scan-
ning confocal microscopy. In contrast, PrPC showed a weak
colocalization with the monoacylated kinase Src. This ¢nding
is in agreement with the observation that acylation, especially
multiple acylation, regulates raft localization [26]. Further-
more, a strong PrPC^Fyn interaction was indicated by the
observation that PrPC was coimmunoprecipitated by anti-
Fyn both in untreated cells and after CD28/CD3 triggering.
This ¢nding is consistent with the already reported enrichment
of Fyn in microdomains of human lymphocytes [24]. How-
ever, because Fyn is an intracellular protein but PrPC is an-
chored to the outer membrane, the protein interaction is likely
to involve intermediate factor(s). In neuronal cells microse-
quence analysis of Fyn immunoprecipitates prompted the
identi¢cation of caveolin-1K and caveolin-1L [18]. In our cell
system, in the absence of caveolin-1, this structural function is
likely to involve ganglioside molecules, as suggested by the
results of the present study. Interestingly, in a recent paper,
Fyn was not found in coimmunoprecipitates with PrPC, and
does not colocalize in cerebellar granule cells lacking caveolin,
as revealed by confocal immuno£uorescence microscopy [27].
This discrepancy may be due to the di¡erent cell type and in
particular to the di¡erent ganglioside pattern between the two
cell types. Indeed, GM3 is the main ganglioside constituent in
T cells, whereas it is present at a very low level in cerebellar
granule cells, where it is virtually absent in the ‘prion domain’.
These ¢ndings, together with our observation of PrPC^Fyn
association in CEM cells, strongly supports a possible role
for gangliosides (mainly GM3) as components involved in
the linking of the extracellular PrPC to the intracellular Fyn
in lymphocytic cells.
From a functional point of view, in cerebellar granule cells
the ‘prion domain’ contains a speci¢c set of signaling compo-
nents and this restriction would limit access of the compo-
nents of other signaling pathways (e.g. Fyn) [27]. In lympho-
cytic cells, where PrPC is involved in the signaling pathway
ending in T cell activation, Fyn and PrPC may be components
of the same transduction pathway.
One of the main novelties of the present study is the dem-
onstration that ZAP-70 was immunoprecipitated by anti-PrP
antibody after triggering through CD28 and CD3. ZAP-70 is
a Syk family kinase, activated via both a self- and an lck-
dependent phosphorylation mechanism [28], which phosphor-
ylates substrates which in turn lead to the subsequent docking
and activation of other Src homology 2-containing molecules
involved in the ampli¢cation and diversi¢cation of T cell re-
ceptor-initiated signaling. During T cell activation, phosphor-
ylated ZAP-70 translocates from the cytoplasmic compart-
ment to the cell plasma membrane microdomains [29],
where it interacts with GM3 [12]. The observation of PrPC^
ZAP-70 coimmunoprecipitation is suggestive of a role for
PrPC in the signaling transduction pathway involved in T cell
activation. It is already known that glial cells are stimulated
by prion protein to activate tyrosine kinase (Lyn and Syk)-
dependent signal transduction cascades [30]. This leads to a
transient release of Ca2þ that results in activation of protein
kinase C and Ca2þ-sensitive tyrosine kinase [31]. Additional
evidence derives from the strict interaction of PrPC with the
neuronal phosphoprotein synapsin Ib and the adapter protein
Grb-2 [32]. Although the physiological role of PrPC in the
signal transduction pathway ending in T cell activation is
not understood, PrPC may act as a membrane receptor trans-
ducer and is speci¢cally regulated by cell activation [8]. In
addition, PrPC in human lymphocytes can modulate the cel-
lular response to proliferative signals [3].
Taken together, the results of the present study provide the
¢rst evidence that PrPC interacts with ZAP-70, indicating that
it can be considered a component of the multimolecular sig-
naling complex within GEM involved in T cell activation.
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